GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.300
+0.030 (1.32%)
May 12, 2025, 4:00 PM - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $5.83 million as of May 12, 2025. Its market cap has increased by 15.76% in one year.
Market Cap
5.83M
Enterprise Value
1.88M
1-Year Change
15.76%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $5.83M, a decrease of -99.38%. That is a compound annual growth rate of -11.50%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |